![Show Menu](styles/mobile-menu.png)
![Page Background](./../common/page-substrates/page0372.jpg)
Cliquez et modifiez le titre
• For advanced stage lymphomas, the indications for the use
of RT have been questioned and debated, and proper
randomized evidence is sparse.
• The modern concept of involved site radiation therapy
(ISRT) reduces late toxicity in advanced Hodgkin
lymphoma.
• RT to residual disease and/or initial bulk benefits some
patients, depending on the chemotherapy regimen used.
The more intensive the chemotherapy regimen, the fewer
patients benefit from RT
Conclusions
Does Radiation Have a Role in Advanced Stage Hodgkin's or Non-Hodgkin
Lymphoma?
Specht L et al. Curr Treat Options Oncol. 2016 Jan;17(1):4.